These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17665292)

  • 21. Hypoxia, glucose metabolism and the Warburg's effect.
    Bartrons R; Caro J
    J Bioenerg Biomembr; 2007 Jun; 39(3):223-9. PubMed ID: 17661163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia-inducible factor 1α mediates the down-regulation of superoxide dismutase 2 in von Hippel-Lindau deficient renal clear cell carcinoma.
    Gao YH; Li CX; Shen SM; Li H; Chen GQ; Wei Q; Wang LS
    Biochem Biophys Res Commun; 2013 May; 435(1):46-51. PubMed ID: 23611775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal cancer: oxygen meets metabolism.
    Haase VH
    Exp Cell Res; 2012 May; 318(9):1057-67. PubMed ID: 22406000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From molecular understanding to clinical advances.
    Lee CH; Motzer RJ
    Nat Rev Urol; 2014 Feb; 11(2):77-9. PubMed ID: 24366347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia upregulates von Hippel-Lindau tumor-suppressor protein through RhoA-dependent activity in renal cell carcinoma.
    Turcotte S; Desrosiers RR; Beliveau R
    Am J Physiol Renal Physiol; 2004 Feb; 286(2):F338-48. PubMed ID: 14583436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (1)H NMR metabolomics analysis of renal cell carcinoma cells: Effect of VHL inactivation on metabolism.
    Cuperlovic-Culf M; Cormier K; Touaibia M; Reyjal J; Robichaud S; Belbraouet M; Turcotte S
    Int J Cancer; 2016 May; 138(10):2439-49. PubMed ID: 26620126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of cancer cell metabolism by hypoxia-inducible factor 1.
    Semenza GL
    Semin Cancer Biol; 2009 Feb; 19(1):12-6. PubMed ID: 19114105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer.
    Maynard MA; Ohh M
    Am J Nephrol; 2004; 24(1):1-13. PubMed ID: 14654728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific oncolytic effect of a new hypoxia-inducible factor-dependent replicative adenovirus on von Hippel-Lindau-defective renal cell carcinomas.
    Cuevas Y; Hernández-Alcoceba R; Aragones J; Naranjo-Suárez S; Castellanos MC; Esteban MA; Martín-Puig S; Landazuri MO; del Peso L
    Cancer Res; 2003 Oct; 63(20):6877-84. PubMed ID: 14583486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VHL and HIF signalling in renal cell carcinogenesis.
    Baldewijns MM; van Vlodrop IJ; Vermeulen PB; Soetekouw PM; van Engeland M; de Bruïne AP
    J Pathol; 2010 Jun; 221(2):125-38. PubMed ID: 20225241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tumor suppressor gene VHL, hypoxia inducible factor, and renal cell carcinoma].
    Zhang YT; Chen N; Zeng H; Zhou Q
    Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):562-4. PubMed ID: 17134554
    [No Abstract]   [Full Text] [Related]  

  • 32. Tuberous sclerosis complex protein 1 expression is affected by VHL Gene alterations and HIF-1α production in sporadic clear-cell renal cell carcinoma.
    Damjanovic SS; Ilic BB; Beleslin Cokic BB; Antic JA; Bankovic JZ; Milicevic IT; Rodic GS; Ilic DS; Todorovic VN; Puskas N; Tulic CD
    Exp Mol Pathol; 2016 Dec; 101(3):323-331. PubMed ID: 27845047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
    Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutant versions of von Hippel-Lindau (VHL) can protect HIF1α from SART1-mediated degradation in clear-cell renal cell carcinoma.
    Ordóñez-Navadijo Á; Fuertes-Yebra E; Acosta-Iborra B; Balsa E; Elorza A; Aragonés J; Landazuri MO
    Oncogene; 2016 Feb; 35(5):587-94. PubMed ID: 25915846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel role of sphingosine kinase-1 in the invasion and angiogenesis of VHL mutant clear cell renal cell carcinoma.
    Salama MF; Carroll B; Adada M; Pulkoski-Gross M; Hannun YA; Obeid LM
    FASEB J; 2015 Jul; 29(7):2803-13. PubMed ID: 25805832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beyond the hypoxia-inducible factor-centric tumour suppressor model of von Hippel-Lindau.
    Roberts AM; Ohh M
    Curr Opin Oncol; 2008 Jan; 20(1):83-9. PubMed ID: 18043261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formation of Renal Cysts and Tumors in Vhl/Trp53-Deficient Mice Requires HIF1α and HIF2α.
    Schönenberger D; Harlander S; Rajski M; Jacobs RA; Lundby AK; Adlesic M; Hejhal T; Wild PJ; Lundby C; Frew IJ
    Cancer Res; 2016 Apr; 76(7):2025-36. PubMed ID: 26759234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of VHL and hypoxia provokes PAX2 up-regulation in clear cell renal cell carcinoma.
    Luu VD; Boysen G; Struckmann K; Casagrande S; von Teichman A; Wild PJ; Sulser T; Schraml P; Moch H
    Clin Cancer Res; 2009 May; 15(10):3297-304. PubMed ID: 19401348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melatonin and the von Hippel-Lindau/HIF-1 oxygen sensing mechanism: A review.
    Vriend J; Reiter RJ
    Biochim Biophys Acta; 2016 Apr; 1865(2):176-83. PubMed ID: 26899267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity.
    Zhang H; Gao P; Fukuda R; Kumar G; Krishnamachary B; Zeller KI; Dang CV; Semenza GL
    Cancer Cell; 2007 May; 11(5):407-20. PubMed ID: 17482131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.